Generation of bi-transgenic pigs overexpressing human lactoferrin and lysozyme in milk

Transgenic Res. 2015 Apr;24(2):365-73. doi: 10.1007/s11248-014-9835-7. Epub 2014 Sep 19.

Abstract

Intensive swine production industry uses antibiotics to treat diseases and improve pig growth. This can not only cause antibiotic resistance, but can also pollute the environment or eventually affect human public health. To date, human lactoferrin (hLF) and human lysozyme (hLZ) have been known as non-adaptive but interactive antimicrobial members and could act in concert against bacteria, which contribute to host defense. Therefore, their expression in pigs might be an alternative strategy for replacing antibiotics in the pig production industry. In our study, we produced hLF and hLZ bi-transgenic pigs and assessed the milk's antibacterial ability. Integration of both transgenes was confirmed by PCR and southern blot. Both the hLF and hLZ were expressed in the mammary gland of bi-transgenic pigs, as detected by western blotting. The expression amounts were 6.5 g/L for hLF and 1.1 mg/L for hLZ using ELISA. Interestingly, pig milk containing hLF and hLZ had synergistic antimicrobial activity. Our results suggest an alternative approach for avoiding the use of antibiotics in the pig industry, which would be of great benefit to the commercial swine production.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Animals, Genetically Modified
  • Anti-Infective Agents / metabolism
  • Gene Expression Regulation
  • Humans
  • Lactoferrin / biosynthesis*
  • Lactoferrin / genetics
  • Milk*
  • Muramidase / biosynthesis*
  • Muramidase / genetics
  • Swine
  • Transgenes / genetics

Substances

  • Anti-Infective Agents
  • LTF protein, human
  • Muramidase
  • Lactoferrin